India vs WorldVerified
India’s first indigenous bird flu vaccine for chickens to be dedicated to nation on 20 November
ICAR-NIHSAD’s H5N1 vaccine targets Clade 2.3.2.1a, for which no specific commercial vaccine is available at present, the release says.

India's first home-grown vaccine against the H5N1 strain of bird flu in chickens will be dedicated to the nation on 20 November by Union Agriculture Minister Shivraj Singh Chouhan.
Chouhan will dedicate the inactivated H5N1 (Clade 2.3.2.1a) Highly Pathogenic Avian Influenza vaccine at the ICAR-National Institute of High Security Animal Diseases (ICAR-NIHSAD) in Bhopal, which developed it. The Agriculture Ministry says it is the first of its kind in India against this clade of the virus.
Why a vaccine is needed
Highly Pathogenic Avian Influenza, commonly called bird flu, is a serious disease of poultry. According to the ministry, outbreaks can cause nearly 100 per cent mortality among infected birds, and the large-scale culling and trade restrictions that follow cause major financial losses to poultry farmers.
The release says the effects reach beyond farms, touching trade, the prices of poultry products and farmers' livelihoods. Since the disease was first detected in India in 2006, more than 500 combined outbreaks of the H5N1 and H5N8 subtypes have been reported in the country.
The cost of an outbreak
The ministry puts the stakes in numbers:
- A major outbreak could reduce India's GDP growth by up to 1.5 per cent.
- More than 20 per cent of the country's poultry population could be at risk if the disease spreads unchecked.
- The 2006 outbreak caused estimated direct and indirect losses of ₹2,200–3,000 crore.
- An outbreak in Manipur led to losses equal to 0.5 per cent of the state's GDP.
A public health concern too
The release also flags the human side. According to the World Health Organization, 1,003 human cases of H5N1 avian influenza, including 479 deaths, have been reported across 25 countries, including India, since 2003.
Studies of the virus show the H5N1 strain known as Clade 2.3.2.1a has been responsible for most bird flu outbreaks in chickens, the ministry said. Recently, infections by this strain have also been detected in other animal species, including mammals, along with three human cases. Controlling its spread, it said, is important to cut losses for poultry farmers and to prevent transmission from chickens to other animals and humans.
What happens next
At present, the release says, no specific commercial vaccine is available against H5N1 of Clade 2.3.2.1a. The ICAR-NIHSAD vaccine aims to fill that gap by protecting against the strains of the virus circulating in the country.
The release does not say when the vaccine will reach poultry farms, how it will be priced or how it will be distributed. Those details are expected to be known only after the dedication on 20 November.
Source: official release by the Ministry of Agriculture & Farmers Welfare, issued through the Press Information Bureau, Government of India (18 NOV 2026 9:38AM by PIB Delhi). Read the full official text: Shri Shivraj Singh Chouhan to dedicate India's First Indigenous H5N1 (Clade 2.3.2.1a) Chicken Vaccine to the Nation on 20 November.
How we verified this
VerifiedEvery fact, figure and quotation is taken from the official PIB release (Release ID 2337716) issued by the Ministry of Agriculture & Farmers Welfare on 18 NOV 2026 9:38AM by PIB Delhi; checked against the source on publication. Story written by BDT from that release; no outside facts added.
Sources
- 1.Shri Shivraj Singh Chouhan to dedicate India's First Indigenous H5N1 (Clade 2.3.2.1a) Chicken Vaccine to the Nation on 20 November — Press Information Bureau, Government of India